Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 29 - June 23, 2004 June 28, 2004
Amgen Submits Fast-Track Palifermin BLA In Mucositis June 25, 2004 By Kim Coghill Amgen Inc. is requesting U.S. regulatory approval under fast-track guidelines for palifermin, a first-in-class investigational compound for oral mucositis. (BioWorld Today)Read More
RSS